3,003
Views
2
CrossRef citations to date
0
Altmetric
Think Piece

Confounding in longitudinal studies in addiction treatment research

, &
Pages 236-242 | Received 18 Feb 2016, Accepted 10 Oct 2016, Published online: 22 Dec 2016

References

  • Baron RM, Kenny DA. 1986. The moderator-mediator variable distinction in social the moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 51:1173–1182.
  • Bird S. 2008. 21st century drugs and statistical science in UK. Surveys, design and statistics subcommittee of the home. Office Scientific Advisory Committee.
  • Bird SM, Fischbacher CM, Graham L, Fraser A. 2015. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release. Addiction. 110:1617–1624.
  • Bukten A, Skurtveit S, Gossop M, Waal H, Stangeland P, Havnes I, Clausen T. 2012. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. Addiction. 107:393–399.
  • Campbell KM, Deck D, Krupski A. 2007. Impact of substance abuse treatment on arrests among opiate users in Washington State. Am J Addict. 16:510–520.
  • Cohen S, Lichtenstein E. 1990. Perceived stress, quitting smoking, and smoking relapse. Health Psychol. 9:466–478.
  • Crowley DM, Coffman DL, Feinberg ME, Greenberg MT, Spoth RL. 2014. Evaluating the impact of implementation factors on family-based prevention programming: methods for strengthening causal inference. Prev Sci. 15:246–255.
  • Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JA. 2013. Methods for dealing with time-dependent confounding. Stat Med. 32:1584–1618.
  • Dennis ML, Scott CK, Funk R, Foss MA. 2005. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 28:S51–S62.
  • Dunn G. 2014. Complier-Average Causal Effect (CACE) estimation. In: Lovric M, editor. International enyclopedia of statistical science. Berlin, Heidelberg: Springer-Verlag; p. 273–274.
  • Dusselier L, Dunn B, Wang Y, Shelley M, Whalen D. 2005. Personal, health, academic, and environmental predictors of stress for residence hall students. J Am Coll Health Health54:15–24.
  • Fewell Z, Hern MA, Wolfe F. 2004. Controlling for time-dependent confounding using marginal structural models. Stata J. 4:402–420.
  • Greenland S, Pearl J, Robins JM. 1999. Causal diagrams for epidemiologic research. Epidemiology. 10:37–48.
  • Griffin BA, Ramchand R, Almirall D, Slaughter ME, Burgette LF, McCaffery DF. 2014. Estimating the causal effects of cumulative treatment episodes for adolescents using marginal structural models and inverse probability of treatment weighting. Drug Alcohol Depend. 136:69–78.
  • Hernan MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM. 2008. Observational studies analysed like randomised experiments an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 19:766–779.
  • Hernán MA, Robins JM. 2016. Causal inference. Boca Raton: Chapman & Hall/CRC, Available from: https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/.
  • Howe CJ, Cole SR, Ostrow DG, Mehta SH, Kirk GD. 2011. A prospective study of alcohol consumption and HIV acquisition among injection drug users. AIDS. 25:221–228.
  • Larney S, Toson B, Burns L, Dolan K. 2012. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. Addiction. 107:372–380.
  • Li L, Evans E, Hser YI. 2010. A marginal structural modeling approach to assess the cumulative effect of drug treatment on the later drug use abstinence. J Drug Issues. 40:221–240.
  • Lind B, Chen SL, Weatherburn D, Mattick R. 2005. The effectiveness of methadone maintenance treatment in controlling crime – an Australian aggregate-level analysis. Br J Criminol. 45:201–211.
  • Magura S, Nwakeze PC, Demsky SY. 1998. Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 93:51–60.
  • Mertens JR, Weisner CM. 2000. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res. 24:1525–1533.
  • National Treatment Agency for Substance Misuse. (2010). Women in drug treatment: what the latest figures reveal. Available from: http://www.nta.nhs.uk/uploads/ntawomenintreatment22march2010.pdf.
  • Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, Montaner JSG. 2015. The effects of opioid substitution treatment and highly active antiretroviral therapy on the cause-specific risk of mortality among HIV-positive people who inject drugs. Clin Infect Dis: Off Publication Infect Dis Soc Am. 61:1157–1165.
  • Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A, Millar T. 2015. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 111:298–308.
  • Pierce M, Bird SM, Hickman M, Millar T. 2015. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005–2009. Drug Alcohol Depend. 146:17–23.
  • Pierce M, Hayhurst K, Bird SM, Hickman M, Seddon T, Dunn G, Millar T. 2015. Quantifying crime associated with drug use among a large cohort of sanctioned offenders in England and Wales. Drug Alcohol Depend. 155:52–59.
  • Prochaska JO, DiClemente CC, Norcross JC. 1992. In search of how people change. Applications to addictive behaviors. Am Psychol. 47:1102–1114.
  • Rehm J, Gmel G, Sempos CT, Trevisan M. 2003. Alcohol-related morbidity and mortality. Alcohol Res Health Alcohol. 27:39–51.
  • Robins J. 1986. A new approach to causal inference in mortality studies with a sustained exposure period – application to control of the healthy worker survivor effect. Math Model. 7:1393–1512.
  • Robins JM, Blevins D, Ritter G, Wulfsohn M. 1992. G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology. 3:319–336.
  • Robins JM, Hernan MA, Brumback B. 2000. Marginal structural models and causal inference in epidemiology. Epidemiology. 11:550–560.
  • Simpson DD, Joe GW, Brown BS. 1997. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 11:294–307.
  • Salmon P. 2001. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev. 21:33–61.
  • Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. 1996. Panic anxiety, dyspnoea, and respiratory disease: theoretical and clinical considerations. Am J Respir Crit Care Med. 154:6–17.
  • Sung M, Erkanli A, Costello EJ. 2014. Estimating the causal effect of conduct disorder on the time from first substance use to substance use disorders using g-estimation. Subst Abuse. 35:141–146.